Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1984;63:48-51
© 1984 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GOLDKRAND, J. W.
Right arrow Articles by BENJAMIN, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GOLDKRAND, J. W.
Right arrow Articles by BENJAMIN, D. S.

Antepartum Fetal Heart Testing

A Clinical Appraisal

JOHN W. GOLDKRAND, MD and DANNY S. BENJAMIN, MD

From the Sinai Hospital of Detroit, Detroit, Michigan.

Abstract

A prospective noncomparative study was designed to test the ability of the nonstress test (NST) and the contraction stress test or oxytocin challenge test (CST/OCT) to predict neonatal morbidity or impending mortality. Two hundred nine pregnancies tested within eight days of delivery were studied. The only two perinatal deaths occurred in association with the postmaturity syndrome, and both had a preceding reactive NST. Some patients (37.57c) with a positive CST/OGT had fetal distress in labor. Ninety-six percent of infants with distress in labor had an antecedent reactive NST. In the study, 25.8% of the patients had a major antepartum, intrapartum, or postpartum complication that was not predicted by the NST. Therefore, electronic antepartum fetal heart rate surveillance was used as only one facet of the overall patient analysis. Management of patients was based upon the combination of antepartum monitoring, real-time ultrasound evaluation of amniotic fluid, and placental morphology, as well as the clinical suspicion of increased risk (using fetal activity testing, etc).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American College of Obstetricians and Gynecologists.